BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30167083)

  • 1. A comprehensive evaluation of Hippo pathway silencing in sarcomas.
    Merritt NM; Fullenkamp CA; Hall SL; Qian Q; Desai C; Thomason J; Lambertz AM; Dupuy AJ; Darbro B; Tanas MR
    Oncotarget; 2018 Aug; 9(60):31620-31636. PubMed ID: 30167083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubule-Specific Mst1/2 Deficiency Induces CKD
    Xu C; Wang L; Zhang Y; Li W; Li J; Wang Y; Meng C; Qin J; Zheng ZH; Lan HY; Mak KK; Huang Y; Xia Y
    J Am Soc Nephrol; 2020 May; 31(5):946-961. PubMed ID: 32253273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
    Seidel C; Schagdarsurengin U; Blümke K; Würl P; Pfeifer GP; Hauptmann S; Taubert H; Dammann R
    Mol Carcinog; 2007 Oct; 46(10):865-71. PubMed ID: 17538946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.
    Rawat SJ; Araiza-Olivera D; Arias-Romero LE; Villamar-Cruz O; Prudnikova TY; Roder H; Chernoff J
    Curr Biol; 2016 Jun; 26(12):1556-1563. PubMed ID: 27238285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
    Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
    Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinases of the Hippo pathway: regulation and substrates.
    Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR
    Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
    Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
    Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mst1 and Mst2 kinases: regulations and diseases.
    Qin F; Tian J; Zhou D; Chen L
    Cell Biosci; 2013 Aug; 3(1):31. PubMed ID: 23985272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MST1/MST2 Protein Kinases: Regulation and Physiologic Roles.
    Galan JA; Avruch J
    Biochemistry; 2016 Oct; 55(39):5507-5519. PubMed ID: 27618557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes.
    St Louis BM; Quagliato SM; Su Y-T; Dyson G; Lee P-C
    mBio; 2024 May; 15(5):e0342923. PubMed ID: 38624208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway.
    Kong Q; Li J; Zhao L; Shi P; Liu X; Bian C; Liu J; Liu T
    Virol J; 2021 Oct; 18(1):214. PubMed ID: 34717661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(rC)-Binding Protein 2 Regulates Hippo Signaling To Control Growth in Breast Epithelial Cells.
    Li F; Bullough KZ; Vashisht AA; Wohlschlegel JA; Philpott CC
    Mol Cell Biol; 2016 Aug; 36(16):2121-31. PubMed ID: 27215387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-canonical Hippo signaling regulates immune responses.
    Chen L
    Adv Immunol; 2019; 144():87-119. PubMed ID: 31699221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippo/Mst signalling couples metabolic state and immune function of CD8α
    Du X; Wen J; Wang Y; Karmaus PWF; Khatamian A; Tan H; Li Y; Guy C; Nguyen TM; Dhungana Y; Neale G; Peng J; Yu J; Chi H
    Nature; 2018 Jun; 558(7708):141-145. PubMed ID: 29849151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo signaling components, Mst1 and Mst2, act as a switch between self-renewal and differentiation in Xenopus hematopoietic and endothelial progenitors.
    Nejigane S; Takahashi S; Haramoto Y; Michiue T; Asashima M
    Int J Dev Biol; 2013; 57(5):407-14. PubMed ID: 23873372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Inactivation of
    Abou Nader N; Blais É; St-Jean G; Boerboom D; Zamberlam G; Boyer A
    J Endocr Soc; 2022 Nov; 7(1):bvac143. PubMed ID: 36405866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas.
    Gao T; Zhou D; Yang C; Singh T; Penzo-Méndez A; Maddipati R; Tzatsos A; Bardeesy N; Avruch J; Stanger BZ
    Gastroenterology; 2013 Jun; 144(7):1543-53, 1553.e1. PubMed ID: 23454691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine.
    Sadri F; Hosseini SF; Rezaei Z; Fereidouni M
    Genes Dis; 2024 Mar; 11(2):760-771. PubMed ID: 37692482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian sterile 20-like kinase 1/2 inhibits the Wnt/β-catenin signalling pathway by directly binding casein kinase 1ε.
    Xu F; Wang YL; Chang JJ; Du SC; Diao L; Jiang N; Wang HJ; Ma D; Zhang J
    Biochem J; 2014 Feb; 458(1):159-69. PubMed ID: 24180524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functions of the Hippo signaling pathway in immune cells.
    Yu SJ; Geng J; Chen LF
    Yi Chuan; 2017 Jul; 39(7):650-658. PubMed ID: 28757479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.